Search Results 911-920 of 11395 for anti-TNF drugs

  1. Clinical trials - Oncology (Medical)

    ... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...

  2. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV) - Mayo Clinic

    The study compares taletrectinib (study drug) versus placebo (sugar pill) in patients with ROS1-fusion positive stage IB, II, IIIA NSCLC. The study will ...

  3. Clonidine (transdermal route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Natalizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Namilumab In Subjects With Chronic Pulmonary Sarcoidosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Use of biologic — approved or investigational agents (e.g., anti-TNFα, anti ...

  6. Trastuzumab-qyyp (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Trastuzumab-qyyp injection is used together with other cancer medicines (eg, doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, ...

  7. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

    The purpose of this study is to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in ...

  8. Hematology - Clinical trials

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  9. Nephrogenic systemic fibrosis - Diagnosis and treatment - Mayo Clinic

    Learn about symptoms, risk factors and possible treatments for this rare disorder in people with advanced kidney disease.

  10. Modified immunosuppressive regimen improves survival in heart transplant patients - Mayo Clinic

    "Prior to 2006, most heart transplant patients at Mayo Clinic in Rochester, Minnesota, received induction therapy consisting of anti-thymocyte globulin (ATG), ...